SWHR Provides Feedback to ICER on Draft Evidence Report on Treatments for Alzheimer’s Disease


Published 2/7/23

SWHR provided feedback to the Institute for Clinical and Economic Review (ICER) in response to its Draft Evidence Report assessing the comparative clinical effectiveness and value of emerging anti-amyloid monoclonal antibodies for the treatment of Alzheimer’s disease.

Read the Letter